Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review.
暂无分享，去创建一个
R. Foà | M. Martelli | G. Valesini | M. Riminucci | F. Conti | L. Massaro | A. Di Rocco | C. Cartoni | E. Finolezzi | S. Grammatico | A. Famà | D. Armiento | C. Minotti | F. De Angelis | G. Colafigli | C. Viccarone
[1] Xiaowen Tang,et al. Research progresses in the pathogenesis of anaplastic large cell lymphoma , 2011, Chinese journal of cancer.
[2] J. Tobias,et al. Lack of TNFα expression protects anaplastic lymphoma kinase-positive T-cell lymphoma (ALK+ TCL) cells from apoptosis , 2009, Proceedings of the National Academy of Sciences.
[3] J. Gelfand,et al. Is there truly a risk of lymphoma from biologic therapies? , 2009, Dermatologic therapy.
[4] E. Matteson,et al. Etanercept therapy in rheumatoid arthritis and the risk of malignancies: a systematic review and individual patient data meta-analysis of randomised controlled trials , 2008, Annals of the rheumatic diseases.
[5] T. Einarson,et al. The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events , 2008, Annals of the rheumatic diseases.
[6] L. Klareskog,et al. Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. , 2003, Arthritis and rheumatism.